Details

Liquid biopsy is a modern technique in cancer medicine that allows for the detection of cancer characteristics by analyzing a blood sample (or other bodily fluids, such as urine). This method can, for example, help in selecting an appropriate treatment, assessing the risk of recurrence, evaluating the success of a treatment, or detecting changes in the disease early on during the course of treatment. Research is also underway to use liquid biopsy for early cancer detection in the future. Thanks to advances in recent years, liquid biopsy is already being used clinically in select situations and can contribute to supporting medical decision-making. However, further research is still needed for other situations. 
This free event hosted by the Cancer Information Service is aimed at cancer patients, their relatives and people in their social circles, as well as anyone else interested.

Program on July 23: 

4:00 PM Welcome 

• Dr. Susanne Weg-Remers, Head of the Krebsinformationsdienst, DKFZ

4:05 PM Liquid Biopsy: Possibilities, Limitations, and Practical Application Examples 

• Dr. Anja Riediger, Clinician Scientist, Department of Translational Medical Oncology at the DKFZ

4:50 p.m. Q&A from the chat

5:20 p.m. Common questions from patients 

• Dr. Eva Krieghoff-Henning, Scientist, Department of Personalized Medical Oncology at the DKFZ

5:40 PM Q&A session via chat

6:00 PM End of the event 

You can register for the event here. 

The presentations will be made available on the website after the event.

The Krebsinformationsdienst (Cancer Information Servicee)is a service offered by the German Cancer Research Center for cancer patients, their families and friends, and anyone seeking advice. Doctors answer all questions about cancer free of charge in an understandable manner and based on the latest scientific findings. You can reach the Krebsinformationsdienst by phone at 06221-420 30 40 or by email krebsinformationsdienst(at)dkfz.de. The website www.krebsinformationsdienst.de also offers reliable information on cancer as well as addresses and links to other quality-assured services.